Table 1. Demographic characteristics of Controls and AMD patients.
| Variables | AMD | Controls |
| Number | 115 | 61 |
| Age | 64.97±7.1 | 60.38±13.2 |
| Duration of disease¥ | 23±2.6 (M) | – |
| Wet AMD | 84 (73.04%) | – |
| Minimal Classic | 7 (11.9%) | – |
| Predominant Classic | 16 (27.1%) | – |
| Occult | 36 (61.0%) | – |
| Familial Cases | 10 (8.7%) | – |
| Bevacizumab Treated | 55 (65.5%) | – |
| Smokers | 50 (43.5%) | 11 (20%) |
| Alcohol User | 37 (32.2%) | 17 (30.9%) |
| Vegetarian | 61 (53%) | 31 (56.4%) |
| Male | 75 (65.2%) | 40 (65.6%) |
Clinical and demographic details of subjects. AMD, age related macular degeneration; M, Months; Age, Age of onset; Values are mean ± SD or (percentage), ¥ Duration of disease is the interval between appearance of first symptom of AMD and collection of sample. AMD subjects were asked to provide all clinical and demographic details at the age of disease-onset.